245 related articles for article (PubMed ID: 31767832)
1. Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization.
Wang F; Sun F; Luo J; Yue T; Chen L; Zhou H; Zhang J; Yang C; Luo X; Zhou Q; Zhu H; Li J; Yang P; Xiong F; Yu Q; Zhang H; Zhang W; Xu A; Zhou Z; Lu Q; Eizirik DL; Zhang S; Wang CY
Cell Death Dis; 2019 Nov; 10(12):892. PubMed ID: 31767832
[TBL] [Abstract][Full Text] [Related]
2. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY
Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
[TBL] [Abstract][Full Text] [Related]
3. SUMOylation of KLF4 promotes IL-4 induced macrophage M2 polarization.
Wang K; Zhou W; Cai Q; Cheng J; Cai R; Xing R
Cell Cycle; 2017 Feb; 16(4):374-381. PubMed ID: 28059602
[TBL] [Abstract][Full Text] [Related]
4. Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage-mediated insulitis is accelerated in a model of autoimmune diabetes.
Emre Y; Hurtaud C; Karaca M; Nubel T; Zavala F; Ricquier D
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):19085-90. PubMed ID: 18006654
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
6. Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice.
Carlos D; Yaochite JN; Rocha FA; Toso VD; Malmegrim KC; Ramos SG; Jamur MC; Oliver C; Camara NO; Andrade MV; Cunha FQ; Silva JS
Eur J Immunol; 2015 Oct; 45(10):2873-85. PubMed ID: 26234742
[TBL] [Abstract][Full Text] [Related]
7. Protein SUMOylation Is Required for Regulatory T Cell Expansion and Function.
Ding X; Wang A; Ma X; Demarque M; Jin W; Xin H; Dejean A; Dong C
Cell Rep; 2016 Jul; 16(4):1055-1066. PubMed ID: 27425617
[TBL] [Abstract][Full Text] [Related]
8. Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes.
Tekula S; Khurana A; Anchi P; Godugu C
Biomed Pharmacother; 2018 Oct; 106():1428-1440. PubMed ID: 30119216
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-Conjugating Enzyme 9 Phosphorylation as a Novel Mechanism for Potentiation of the Inflammatory Response.
Tomasi ML; Ramani K; Ryoo M
Am J Pathol; 2016 Sep; 186(9):2326-36. PubMed ID: 27561301
[TBL] [Abstract][Full Text] [Related]
10. Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: implications for diabetic ventricular dysfunction after myocardial infarction.
Shishido T; Woo CH; Ding B; McClain C; Molina CA; Yan C; Yang J; Abe J
Circ Res; 2008 Jun; 102(11):1416-25. PubMed ID: 18467627
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Arafat HA; Lada E; Katakam AK; Amin N
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):555-62. PubMed ID: 17177137
[TBL] [Abstract][Full Text] [Related]
12. Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells.
Yukita A; Hosoya A; Ito Y; Katagiri T; Asashima M; Nakamura H
Bone; 2012 May; 50(5):1092-9. PubMed ID: 22366399
[TBL] [Abstract][Full Text] [Related]
13. UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts.
Gupta MK; McLendon PM; Gulick J; James J; Khalili K; Robbins J
Circ Res; 2016 Jun; 118(12):1894-905. PubMed ID: 27142163
[TBL] [Abstract][Full Text] [Related]
14. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
[TBL] [Abstract][Full Text] [Related]
15.
Wang A; Ding X; Demarque M; Liu X; Pan D; Xin H; Zhong B; Wang X; Dejean A; Jin W; Dong C
J Immunol; 2017 May; 198(9):3461-3470. PubMed ID: 28314856
[TBL] [Abstract][Full Text] [Related]
16. Ubc9 regulates the expression of MHC II in dendritic cells to enhance DSS-induced colitis by mediating RBPJ SUMOylation.
Zhang J; Chen L; Xu Q; Zou Y; Sun F; Zhou Q; Luo X; Li Y; Chen C; Zhang S; Xiong F; Yang P; Liu S; Wang CY
Cell Death Dis; 2023 Nov; 14(11):737. PubMed ID: 37957143
[TBL] [Abstract][Full Text] [Related]
17. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
[TBL] [Abstract][Full Text] [Related]
18. Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.
Gupta MK; Gulick J; Liu R; Wang X; Molkentin JD; Robbins J
Circ Res; 2014 Sep; 115(8):721-9. PubMed ID: 25097219
[TBL] [Abstract][Full Text] [Related]
19. S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers.
Tomasi ML; Tomasi I; Ramani K; Pascale RM; Xu J; Giordano P; Mato JM; Lu SC
Hepatology; 2012 Sep; 56(3):982-93. PubMed ID: 22407595
[TBL] [Abstract][Full Text] [Related]
20. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency.
López I; Chalatsi E; Ellenbroek SIJ; Andrieux A; Roux PF; Cerapio JP; Jouvion G; van Rheenen J; Seeler JS; Dejean A
Oncogene; 2020 Oct; 39(43):6692-6703. PubMed ID: 32948837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
